News Digging > News > FDA Grants Orphan Designation to PTX-100 for TCL Indications
FDA Grants Orphan Designation to PTX-100 for TCL Indications
FDA Grants Orphan Designation to PTX-100 for TCL Indications,Clinical-stage oncology company Prescient Therapeutics (ASX:PTX) has announced that the US FDA has granted Orphan Drug Designation for PTX-100 for the

FDA Grants Orphan Designation to PTX-100 for TCL Indications

Clinical-stage oncology company Prescient Therapeutics (ASX:PTX) has announced that the US FDA has granted Orphan Drug Designation for PTX-100 for the